Deep Track Capital LP 13D and 13G filings for Oruka Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 4:32 pm Purchase | 2025-05-06 | 13G | Oruka Therapeutics, Inc. ORKA | Deep Track Capital LP | 1,896,780 5.070% | 1,896,780 (New Position) | Filing |